Sort
51,593 grants matching “hepatitis”
Physiological Importance of Growth Hormone Pulsatility
$420,339University Of Michigan At Ann Arbor · R01 · FY2004 · DK
Pathogenesis of Infectious Diseases Training Program
$420,337Roy M Gulick · Weill Medical Coll Of Cornell Univ · T32 · FY2013 · AI
Inhaled inhibitors of TGFB activation by integrins
$420,311Dean Sheppard · University Of California, San Francisco · P01 · FY2013 · HL
Cross-talk between iron metabolism and intestinal inflammation
$420,300Bobby Joseph Cherayil · Massachusetts General Hospital · R01 · FY2016 · AI
Qualitative Exploration of Low-Frequency Heroin Injectors Not in Drug Treatment
$420,296Alexander H Kral · Research Triangle Institute · R01 · FY2007 · DA
Preservation of Beta Cells by Glutamate Decarboxylase
$420,263Diane K Wherrett · Hospital For Sick Chldrn (Toronto) · U01 · FY2007 · DK
Fidelity, robustness, and diversity in RNA virus evolution and pathogenesis
$420,259Adam Lauring · University Of Michigan At Ann Arbor · R01 · FY2017 · AI
IMMUNE RESPONSES TO AAV IN GENE TRANSFER FOR HEMOPHILIA
$420,249Katherine High · Wistar Institute · P01 · FY2008 · HL
Arginine regulation of alpha cell proliferation and function
$420,170Erika Danielle Dean · Vanderbilt University Medical Center · R01 · FY2022 · DK
Targeting DAMPs in Alcoholic Hepatitis
$420,170Robert F. Schwabe · Columbia University Health Sciences · U01 · FY2013 · AA
Hexokinase 2 in liver cancer
$420,150Nissim Hay · University Of Illinois At Chicago · R01 · FY2019 · CA
Therapeutic Potential of Estrogen-Regulated Metabolism and Cardiovascular Risk
$420,145John Micheal Stafford · Vanderbilt University Medical Center · R01 · FY2023 · DK
Immunopathogenesis of Non-alcoholic Fatty Liver Disease
$420,135Senad Divanovic · Cincinnati Childrens Hosp Med Ctr · R01 · FY2015 · DK
Preclinical Diagnostic Imaging of Amyloid
$420,101Jonathan S Wall · University Of Tennessee Knoxville · R01 · FY2011 · DK
Impact of Eliminating Extended Duration Work Shifts on Resident Health and Safety
$420,090Laura K. Barger · Brigham And Women'S Hospital · R01 · FY2013 · OH
The Role of KLF6 Tumor Suppressor in Hepatocellular Cancer
$420,063Scott Laurence Friedman · Icahn School Of Medicine At Mount Sinai · R01 · FY2010 · DK
The Role of KLF6 Tumor Suppressor in Hepatocellular Cancer
$420,063Scott Laurence Friedman · Icahn School Of Medicine At Mount Sinai · R01 · FY2009 · DK
GENETIC ANALYSIS OF CORONAVIRUS ASSEMBLY INTERACTIONS
$420,062Paul Scott Masters · Wadsworth Center · R01 · FY2008 · AI
NIDA Clinical Trials Network: Greater New York Node
$420,013John P Rotrosen · New York University School Of Medicine · UG1 · FY2019 · DA
Drug Metabolism and Chronic Liver Disease
$420,008University Of Pittsburgh At Pittsburgh · R01 · FY2004 · DK
Development of a Novel TGF-beta Antagonist for Treating Hepatic Fibrosis
$420,003Jung S. Huang · Saint Louis University · RC1 · FY2010 · AA
New insights into the functional diversity of the hepatic antiviral T cell response during hepacivirus infection in vivo
$420,000Eva Billerbeck · Albert Einstein College Of Medicine · R01 · FY2024 · AI
Cortical representations and plasticity: Neurons and astrocytes
$420,000Mriganka Sur · Massachusetts Institute Of Technology · R01 · FY2009 · EY
Role of HCV p7 and NS2 in infectious virus production
$420,000Charles M. Rice · Rockefeller University · R01 · FY2008 · AI
New insights into the functional diversity of the hepatic antiviral T cell response during hepacivirus infection in vivo
$420,000Eva Billerbeck · Albert Einstein College Of Medicine · R01 · FY2023 · AI